Patents Assigned to Molecular Research Institute
  • Publication number: 20080027038
    Abstract: Compounds of structural formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
    Type: Application
    Filed: August 20, 2007
    Publication date: January 31, 2008
    Applicants: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: HIdenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okumo, Kiyoshi Inoguchi, Ping Huang, Gilda Loew
  • Patent number: 7279573
    Abstract: Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: October 9, 2007
    Assignees: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Hidenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okuno, Kiyoshi Inoguchi, Ping Huang, Gilda Loew
  • Publication number: 20060142264
    Abstract: Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
    Type: Application
    Filed: February 23, 2006
    Publication date: June 29, 2006
    Applicants: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Hidenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okuno, Kiyoshi Inoguchi, Ping Huang, Gilda Loew
  • Patent number: 7064121
    Abstract: Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals
    Type: Grant
    Filed: October 13, 2004
    Date of Patent: June 20, 2006
    Assignees: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Hidenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okuno, Kiyoshi Inoguchi, Ping Huang, Gilda Loew
  • Patent number: 7022677
    Abstract: Disclosed are the novel compounds as growth hormone secretagogues represented by structural Formula (I), wherein R1 is, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl, or substituted or unsubstituted amino, X is —CO— or —SO2—, Y is Formula (II), wherein n is an integer from 0–4, R4 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, R5 and R6 are independently selected from hydrogen, substituted or unsubstituted alkyl, or R5 and R6 or R4 and R5 are taken together to form substituted or unsubstituted alkylene, R2 is hydrogen, or substituted or unsubstituted alkyl, R3 is substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, D is substituted or unsubstituted amino, substituted or unsubstituted alkoxy, or substituted or unsubstituted alkylthio, * represents an asymmetric center, and ph
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: April 4, 2006
    Assignees: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Nobuo Ishiyama, Hirohide Ishige, Mitsuo Mimura, Tadashi Okuno, Kiyoharu Ukai, Takeshi Kiyofuji, Shinji Tauchi, Kiyoshi Inoguchi, Ping Huang, Linda J. Maki, legal representative, Gilda H. Loew, deceased
  • Publication number: 20060014701
    Abstract: Disclosed are the novel compounds as growth hormone secretagogues represented by the structural Formula I: wherein R1 is, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl, or substituted or unsubstituted amino, X is —CO— or —SO2—, Y is: wherein n is an integer from 0-4, R4 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, R5 and R6 are independently selected from hydrogen, substituted or unsubstituted alkyl, or R5 and R6 or R4 and R5 are taken together to form substituted or unsubstituted alkylene, R2 is hydrogen, or substituted or unsubstituted alkyl, R3 is substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, D is substituted or unsubstituted amino, substituted or unsubstituted alkoxy, or substituted or unsubstituted alkylthio, * represents an asymmetric center, and phar
    Type: Application
    Filed: September 6, 2005
    Publication date: January 19, 2006
    Applicants: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Nobuo Ishiyama, Hirohide Ishige, Mitsuo Mimura, Tadashi Okuno, Kiyoharu Ukai, Takeshi Kiyofuji, Shinji Tauchi, Kiyoshi Inoguchi, Ping Huang, Gilda Loew, Linda Maki
  • Publication number: 20050059699
    Abstract: Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
    Type: Application
    Filed: October 13, 2004
    Publication date: March 17, 2005
    Applicants: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Hidenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okuno, Kiyoshi Inoguchi, Ping Huang, Gilda Loew
  • Patent number: 6864250
    Abstract: Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals
    Type: Grant
    Filed: August 20, 1998
    Date of Patent: March 8, 2005
    Assignees: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Hidenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okuno, Kiyoshi Inoguchi, Ping Huang, Gilda Loew